top of page

Mwandishi:

Dkt. Mercy M, CO

Mhariri:

Dkt. Sospeter M, MD

kirusi mumps-ulyclinic

Tetrabenazine ni moja kati ya dawa inayotumika kupunguza miondoko isiyokuwa ya kawaida (chorea) inayosababishwa na magonjwa ya huntington.


Majina mengine ya Tetrabenazine


Majina mengine ya Tetrabenazine ni;


  • Xenazine

  • Nitoman


Tetrabenazine ipo kundi gani la dawa?


Tetrabanazine ni dawa iliyo katika kundi la VMAT2 Inhibitors.


Dawa zilizo kundi moja na Tetrabenazine


Dawa zilizo kundi moja na Tetrabenazine ni;


  • Deutetrabenazine

  • Valbenazine


Fomu ya dawa ya Tetrabenazine


Dawa hii ipo katika fomu ya kidonge


Uzito wa dawa ya Tetrabenazine


Tetrabenazine ina uzito ufuatao;


Vidonge


  • 12.5mg

  • 25mg



Tetrabenazine hutibu nini?


Hutumika kutibu ugonjwa wa huntington.


Namna Tetrabenazine inavyoweza kufanya kazi


Tetrabenazine hufanya kazi kwa kuzuia human vesicular monoamine transporter type 2 (VMAT2) hivyo kupunguza monoamines inayozalishwa kwenye nevu ya synaptic na depletion ya monoamine stores kutoka kwenye nevu.


Ufyozwaji wa dawa

Ufyozwaji wa dawa hii hufanyika kwenye mfumo wa chakula hadi asilimia sabini na tano.


Mwingiliano wa Tetrabenazine na chakula


Dawa hii inaweza kutumika mtu akiwa amepata chakula au akiwa hajapata chakula.


Wagonjwa wasiopaswa kutumia Tetrabenazine


  • Wagonjwa wenye mzio wa Tetrabenazine.

  • Wagonjwa wenye mzio wa dawa jamii ya VMAT2 Inhibitors.


Utoaji taka wa Tetrabenazine mwilini


Asilimia sabini na tano (75%) ya Dawa hii hutolewa njee kwa njia ya mkojo na asilimia saba hadi kumi na sita (7%-16%) hutolewa kwa njia ya haja kubwa.


Matumizi ya Tetrabenazine kwa mama mjamzito


Hakuna tafiti zinazoonesha madhara ya dawa hii kwa mama mjamzito na kwa mtoto aliyeko tumboni hivyo tahadhari inatakiwa wakati mama anatumia dawa hii.



Matumizi ya Tetrabenazine kwa mama anayenyonyesha


Hakuna tafiti zinazoonesha kuwa dawa hii inaweza kuleta madhara kwa mama anayenyonysha, kwa mtoto anayenyosha na katika uzalishwaji wa maziwa. Hivyo tahadhari inatakiwa wakati mama anatumia dawa hii.


Dawa zenye muingiliano na Tetrabenazine



Dawa zenye mwingiliano mkali na hivyo kutofaa kutumika pamoja na Tetrabenazine;

  • Alfuzosin

  • Apomorphine

  • Aripiprazole

  • Artemether

  • Atomoxetine

  • Bedaquiline

  • Ceritinib

  • Dofetilide

  • Encorafenib

  • Entrectinib

  • Eribulin

  • Escitalopram

  • Fexinidazole

  • Glasdegib

  • Histrelin

  • Hydroxychloroquine sulfate

  • Inotuzumab

  • Iobenguane i 131

  • Lefamulin

  • Mefloquine

  • Metoclopramide intranasal

  • Panobinostat

  • Pimavanserin

  • Pitolisant

  • Ribociclib

  • Safinamide

  • Triptorelin


Dawa zinazoweza kutumika na Tetrabenazine chini ya uangalizi;

  • Abiraterone

  • Albuterol

  • Alfuzosin

  • Amoxapine

  • Arformoterol

  • Aripiprazole

  • Brexanolone

  • Cenobamate

  • Chlorpromazine

  • Ciprofloxacin

  • Clobazam

  • Clozapine

  • Fluoxetine

  • Fluphenazine

  • Fostemsavir

  • Haloperidol

  • Iloperidone

  • Lasmiditan

  • Lemborexant

  • Lenvatinib

  • Lofexidine

  • Metoclopramide

  • Paliperidone

  • Paroxetine

  • Perphenazine

  • Pimozide

  • Prochlorperazine

  • Promethazine

  • Quetiapine

  • Quinidine

  • Remimazolam

  • Risperidone

  • Ritonavir

  • Selpercatinib

  • Stiripentol

  • Thioridazine

  • Thiothixene

  • Triclabendazole

  • Trifluoperazine

  • Voclosporin

  • Ziprasidone


Dawa zenye mwingiliano mdogo na Tetrabenazine;

  • Azithromycin

  • Chloroquine


Maudhi madogo ya Tetrabenazine;


  • Inaleta usingizi

  • Mwili kuchoka

  • Kukosa usingizi

  • Msongo wa mawazo

  • Akathisia

  • kutapika

  • Kukosa hamu ya kula

  • Kizunguzungu

  • Maumivu ya kichwa

  • Extrapyramidal events

  • Kupata woga

  • Kichefuchefu

  • Bruising

  • Maumivu wakati wa kukojoa


Ufanye nini endapo utasahau kutumia dozi yako?


Kama umesahau kutumia dozi yako tumia mara pale utakapokumbuka, kama muda wa dozi inayofata umekaribia usimeze dozi uliyosahau endelea na dozi inayofuata kwa muda uliopangiwa na daktari. Usimeze dozi mbili kufidia uliyosahau.

13 Juni 2023 19:18:46

Dawa Tetrabenazine

Imeboreshwa,

29 Oktoba 2021 13:56:57

Dawa yoyote ni sumu, usitumie dawa pasipo ushauri wa daktari kuepuka madhara kwenye ogani mbalimbali kama figo na ini. Matumizi ya dawa pasipo ushauri wa daktari unaweza kusababisha madhara na usugu wa vimelea vya maradhi kwenye dawa.

ULY CLINIC inakushauri siku zote uwasiliane na daktari wako kwa ushauri na tiba kabla ya kuchukua hatua yoyote ile baad aya kusoma makala hii.

Kupata ushauri zaidi na tiba kutoka kwa daktari wa ULY CLINIC bofya Mawasiliano yetu au Pata tiba.

Rejea za mada hii:

  1. Bäck SE, et al. Age dependence of renal function: clearance of iohexol and p-amino hippurate in healthy males. Scand J Clin Lab Invest. 1989 Nov;49(7):641–646.

  2. Bax RP, et al. The pharmacokinetics of meropenem in volunteers. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):311–320.

  3. Burman LA, et al. Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem. J Antimicrob Chemother. 1991 Feb;27(2):219–224.

  4. Christensson BA, et al. Pharmacokinetics of meropenem in subjects with various degrees of renal impairment. Antimicrob Agents Chemother. 1992 Jul;36(7):1532–1537. 

  5. DAVIES DF, SHOCK NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. 1950 May;29(5):496–507.

  6. Douglas JG, et al. The pharmacokinetics of cefuroxime in the elderly. J Antimicrob Chemother. 1980 Jul;6(4):543–549.

  7. Granerus G, et al. Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate. Scand J Clin Lab Invest. 1981 Oct;41(6):611–616.

  8. Harrison MP, et al. The disposition and metabolism of meropenem in laboratory animals and man. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):265–277. 

  9. Jones RN, et al. In-vitro studies of meropenem. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):9–29. 

  10. Krutzén E, et al. Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. J Lab Clin Med. 1984 Dec;104(6):955–961.

  11. Ljungberg B, et al. Pharmacokinetics of antimicrobial agents in the elderly. Rev Infect Dis. 1987 Mar-Apr;9(2):250–264.

bottom of page